Literature DB >> 24847691

Antenatal betamethasone increases vascular reactivity to endothelin-1 by upregulation of CD38/cADPR signaling.

J-H Lee1, J Zhang1, G A Massmann1, J P Figueroa1.   

Abstract

Antenatal steroid administration is associated with hypertension in adult life; however, the mechanisms underlying this phenomenon are unclear. The aim of this study was to further characterize the effects of antenatal glucocorticoid exposure on the endothelin (ET-1) system, specifically to ascertain the role of the cyclic adenosine diphosphate ribose (cADPR)/ryanodine receptor pathway in the increased sensitivity to ET-1 observed in the offspring exposed to antenatal glucocorticoids. Pregnant sheep were randomly treated with betamethasone (Beta; 0.17 mg/kg) or vehicle at 80 and 81 days of gestation. In adults, we studied endothelium-denuded arterial segments of the brachial arteries. ET-1-induced vasoconstriction was significantly higher in the arteries from Beta sheep (F=3.5, P<0.05). Inhibition of ADP-ribosyl cyclase with 2-2'-dihydroxy-azobenzene significantly decreased the ET-1-induced contraction in Beta but not in vehicle-treated sheep. Nicotinamide attenuated ET-1 contraction in both, but it was significantly more pronounced in the Beta-treated sheep. No significant differences were observed following KCl-induced (6.25-75 mM) contraction. Nicotinamide (10 mM) significantly attenuated the KCl-induced vasoconstriction in both groups. In KCl (62.5 mM)-constricted arteries, the effect of nicotinamide (NIC) was significantly greater in the vehicle-treated sheep (50% relaxation v. 40% relaxation; t=2.2, P<0.05). In contrast, the sodium nitroprusside (SNP) relaxation was not statistically different. An additive effect was observed when NIC and SNP were used in combination and it was also more pronounced in vehicle-treated sheep. We conclude that the increased response to ET-1 is mediated by activation of the CD38/cADPR signaling pathway. Further studies are required to identify the effectors downstream from cADPR affected by exposure to antenatal steroids.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24847691      PMCID: PMC4160102          DOI: 10.1017/S2040174413000512

Source DB:  PubMed          Journal:  J Dev Orig Health Dis        ISSN: 2040-1744            Impact factor:   2.401


  40 in total

1.  Nitric oxide inhibits Ca(2+) mobilization through cADP-ribose signaling in coronary arterial smooth muscle cells.

Authors:  J Z Yu; D X Zhang; A P Zou; W B Campbell; P L Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-09       Impact factor: 4.733

2.  Inhibition of cADP-ribose formation produces vasodilation in bovine coronary arteries.

Authors:  J Geiger; A P Zou; W B Campbell; P L Li
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

3.  Antenatal corticosteroids and outcome at 14 years of age in children with birth weight less than 1501 grams.

Authors:  L W Doyle; G W Ford; A L Rickards; E A Kelly; N M Davis; C Callanan; A Olinsky
Journal:  Pediatrics       Date:  2000-07       Impact factor: 7.124

4.  ADP-Ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation.

Authors:  F G de Toledo; J Cheng; M Liang; E N Chini; T P Dousa
Journal:  Circ Res       Date:  2000-06-09       Impact factor: 17.367

Review 5.  Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers.

Authors:  H C Lee
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

6.  Endothelin-1-induced contraction of mesenteric small arteries is mediated by ryanodine receptor Ca2+ channels and cyclic ADP-ribose.

Authors:  A D Giulumian; L G Meszaros; L C Fuchs
Journal:  J Cardiovasc Pharmacol       Date:  2000-12       Impact factor: 3.105

7.  Effect of nitric oxide on calcium-induced calcium release in coronary arterial smooth muscle.

Authors:  N Li; A P Zou; Z D Ge; W B Campbell; P L Li
Journal:  Gen Pharmacol       Date:  2000-07

Review 8.  Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology.

Authors:  P D'Orléans-Juste; J Labonté; G Bkaily; S Choufani; M Plante; J C Honoré
Journal:  Pharmacol Ther       Date:  2002-09       Impact factor: 12.310

9.  Calcium-induced calcium release and cyclic ADP-ribose-mediated signaling in the myocytes from small coronary arteries.

Authors:  David X Zhang; Michael D Harrison; Pin-Lan Li
Journal:  Microvasc Res       Date:  2002-09       Impact factor: 3.514

10.  A pivotal role for cADPR-mediated Ca2+ signaling: regulation of endothelin-induced contraction in peritubular smooth muscle cells.

Authors:  Fortunata Barone; Armando A Genazzani; Antonio Conti; Grant C Churchill; Fioretta Palombi; Elio Ziparo; Vincenzo Sorrentino; Antony Galione; Antonio Filippini
Journal:  FASEB J       Date:  2002-05       Impact factor: 5.191

View more
  6 in total

1.  Immunoneutralization of human angiotensin-(1-12) with a monoclonal antibody in a humanized model of hypertension.

Authors:  Carlos M Ferrario; Jessica L VonCannon; Jie Zhang; Jorge P Figueroa; Kendra N Wright; Leanne Groban; Amit Saha; J Wayne Meredith; Sarfaraz Ahmad
Journal:  Peptides       Date:  2021-12-18       Impact factor: 3.750

2.  The association of various obstetric and perinatal factors with retinopathy of prematurity.

Authors:  Ozlem Ozgur Gursoy; Hulusi Goktug Gurer; Ceren Yildiz Eren; Pinar Erdogan Ozgur; Huseyin Gursoy
Journal:  Int Ophthalmol       Date:  2022-03-29       Impact factor: 2.029

Review 3.  The nonhuman primate hypothalamo-pituitary-adrenal axis is an orchestrator of programming-aging interactions: role of nutrition.

Authors:  Peter W Nathanielsz; Hillary F Huber; Cun Li; Geoffrey D Clarke; Anderson H Kuo; Elena Zambrano
Journal:  Nutr Rev       Date:  2020-12-01       Impact factor: 7.110

Review 4.  Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis.

Authors:  Frank Verhoeven; Clément Prati; Katy Maguin-Gaté; Daniel Wendling; Céline Demougeot
Journal:  Arthritis Res Ther       Date:  2016-11-05       Impact factor: 5.156

Review 5.  CD38/cADPR Signaling Pathway in Airway Disease: Regulatory Mechanisms.

Authors:  Deepak A Deshpande; Alonso G P Guedes; Richard Graeff; Soner Dogan; Subbaya Subramanian; Timothy F Walseth; Mathur S Kannan
Journal:  Mediators Inflamm       Date:  2018-02-07       Impact factor: 4.711

Review 6.  Recent Advances in Studies on the Role of Neuroendocrine Disorders in Obstructive Sleep Apnea-Hypopnea Syndrome-Related Atherosclerosis.

Authors:  Wanda Wang; Yanli Zheng; Meimei Li; Shu Lin; Huili Lin
Journal:  Nat Sci Sleep       Date:  2021-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.